Effect of the iridocorneal angle size on the diurnal pressure profile in a glaucoma suspect cohort and patients with glaucoma.

Journal Information

Full Title: Int Ophthalmol

Abbreviation: Int Ophthalmol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Ophthalmology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of InterestM. Müller: Consultant for Théa, Alcon, Novartis, Allergan. A. Pavlovic: No financial interests to declare. T. Niermann: No financial interests to declare. I. Pavlovic: No financial interests to declare. M. Mackert: No financial interests to declare. S. Priglinger: Consultant for Oertli and Novartis; Grants from Alcon, Bayer, Novartis, and Zeiss. M. Shajari: Consultant for Alcon, Zeiss, Staar, and Oculus. T. Kohnen: Consultant and Research for Abbott/J&J, Alcon/Novartis, Avedro, Oculentis, Oculus, Presbia, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Dompé, Geuder, Med Update, Merck, Rayner, Santen, Staar, Tear Lab, Théa, Thieme, Ziemer. Research for Hoya. Ethical approvalThe study protocol of this retrospective study was approved by the ethics committee of the Goethe University, Frankfurt am Main, Germany. Informed consentWritten informed consent was not required, because data were analysed in a pseudonymic way. Conflict of Interest M. Müller: Consultant for Théa, Alcon, Novartis, Allergan. A. Pavlovic: No financial interests to declare. T. Niermann: No financial interests to declare. I. Pavlovic: No financial interests to declare. M. Mackert: No financial interests to declare. S. Priglinger: Consultant for Oertli and Novartis; Grants from Alcon, Bayer, Novartis, and Zeiss. M. Shajari: Consultant for Alcon, Zeiss, Staar, and Oculus. T. Kohnen: Consultant and Research for Abbott/J&J, Alcon/Novartis, Avedro, Oculentis, Oculus, Presbia, Schwind, Zeiss. Consultant for Allergan, Bausch & Lomb, Dompé, Geuder, Med Update, Merck, Rayner, Santen, Staar, Tear Lab, Théa, Thieme, Ziemer. Research for Hoya."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL. There was no funding regarding this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025